급성 뇌경색 환자의 경구 항응고제 치료에서 5 mg과 10 mg 와파린 부하 용량의 비교

키워드

참고문헌 (25)

1. Fuster V, "American College of Cardiology", American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC, ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology, pp.American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society, Circulation[DOI]
2. "Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group", Lancet, 342, pp.1255~1262 (1993)
3. "Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials", Arch Intern Med, 154, pp.1449~1457 (1994)
4. Sacco RL, "American Heart Association", American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association, Circulation, pp.2003, 113[DOI]
5. Albers GW, "American College of Chest Physicians. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)", Chest, 133, pp.630S~669S (2008)
6. Sandercock PA, "Anticoagulants for acute ischaemic stroke", Cochrane Database Syst Rev, pp.CD000024~ (2008)
7. Levine MN, "Hemorrhagic complications of anticoagulant treatment", Chest, 119, pp.108S~121S (2001)
8. van der Meer FJ, "Bleeding complications in oral anticoagulant therapy. An analysis of risk factors", Arch Intern Med, 153, pp.1557~1562 (1993)
9. Ansell J, "American College of Chest Physicians. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition)", Chest, 133, pp.160S~198S (2008)
10. Harrison L, "Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy", Ann Intern Med, 126, pp.133~136 (1997)
11. Crowther MA, "A randomized trial comparing 5-mg and 10-mg warfarin loading doses", Arch Intern Med, 159, pp.46~48 (1999)
12. Kovacs MJ, "Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease", Haemostasis, 28, pp.62~69 (1998)
13. Kovacs MJ, "Prospective assessment of a nomogram for the initiation of oral anticoagulation therapy for outpatient treatment of venous thromboembolism", Pathophysiol Haemost Thromb, 32, pp.131~133 (2002)
14. Kovacs MJ, "Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, doubleblind controlled trial", Ann Intern Med, 138, pp.714~719 (2003)
15. Hylek EM, "Risk factors for intracranial hemorrhage in outpatients taking warfarin", Ann Intern Med, 120, pp.897~902 (1994)
16. Landefeld CS, "Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remedial lesions", Am J Med, 87, pp.153~159 (1989)
17. Adams HP Jr, "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment", Stroke, 24, pp.35~41 (1993)
18. Hacke W, "ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke", N Engl J Med, 359, pp.1317~1329 (2008)
19. Levine M, "A comparison of low-molecularweight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis", N Engl J Med, 334, pp.677~681 (1996)
20. Adams HP Jr, "American Heart Association", American Stroke Association Stroke Council; American Heart Association, American Stroke Association Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease Working Group; Quality of Care Outcomes in Research Interdisciplinary Working Group, pp.Circulation, 2007[DOI]
21. Hallevi H, "Anticoagulation after cardioembolic stroke: to bridge or not to bridge?", Arch Neurol, 65, pp.1169~1173 (2008)
22. Ferro JM, "Cardioembolic stroke: an update", Lancet Neurol, pp.177~188 (2003)
23. Yoo SH, "Age and body weight adjusted warfarin initiation program for ischaemic stroke patients.", Eur J Neurol, 16, pp.1100~1105 (2009)
24. Wells PS, "Interactions of warfarin with drugs and food", Ann Intern Med, 121, pp.676~683 (1994)
25. Gage BF, "Management and dosing of warfarin therapy", Am J Med, 109, pp.481~488 (2000)

관련 논문AI추천